Literature DB >> 17095137

Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants.

Lieselotte Kirchner1, Hanns Helmer, Georg Heinze, Martin Wald, Mathias Brunbauer, Manfred Weninger, Daniela Zaknun.   

Abstract

OBJECTIVE: To investigate the influence of culture proven intrauterine infection on preterm morbidity and to test the effect of antimicrobial treatment.
METHODS: Retrospective cohort study conducted between October 1997 and February 2001 in patients with preterm premature rupture of membranes or preterm labor. Vaginal swabs were sampled and amniocentesis for microbiologic culture of the amniotic fluid was performed. Patients with Ureaplasma urealyticum in the amniotic fluid were treated with josamycin. Infants were followed post partum according to birth weight, gestational age, APGAR score and infant morbidity.
RESULTS: In 49 eligible patients, 40% of cultures were positive, 22% for Ureaplasma urealyticum, 12% for other bacteria and 6% for candida. Children of mothers with positive amniotic fluid cultures had significantly lower gestational ages (26+4 weeks for Ureaplasma urealyticum [p=0.04] and 25+5 weeks for other microorganisms [p=0.0017] versus 28+6 weeks for mothers with negative amniotic fluid cultures) and lower birth weights (975 g [n.s.] and 828 g [p=0.0072] versus 1,041 g) but were appropriate for their gestational ages. 33.3% and 66.7% versus 24% of the children were mechanically ventilated [n.s.], duration of mechanical ventilation was 5.3 [p=0.02] and 10.1 days [p=0.04] versus 1.4 days, and prevalence of chronic lung disease was 38% and 33% versus 11% [n.s.]. Prevalence of severe intraventricular hemorrhage (12.5% [n.s.] and 33% [p=0.04] versus 3.4%) and nosocomial infections (50% for both groups of positive cultures versus 10.3% for negative cultures, p=0.02 and 0.03, respectively) was higher and median length of stay was significantly longer (121 [p=0.02] and 107 days [p=0.03] versus 60 days) in these patients. Maternal positive vaginal swab cultures were not associated with any of the above-mentioned factors. In none of the patients treated with macrolids for proven Ureaplasma urealyticum amnionitis could the microbes be eradicated.
CONCLUSION: Maternal positive amniotic fluid cultures have been associated with lower gestational age and lower birth weight. Rate of infant morbidity was higher and length of stay was significantly longer in this group. Positive vaginal swabs were not predictive for infant morbidity. Treatment of mothers showing positive amniotic fluid cultures with macrolids was not effective.

Entities:  

Mesh:

Year:  2006        PMID: 17095137     DOI: 10.1016/j.ejogrb.2006.09.013

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  27 in total

1.  Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model.

Authors:  Edward P Acosta; Peta L Grigsby; Kajal B Larson; Amanda M James; Mary C Long; Lynn B Duffy; Ken B Waites; Miles J Novy
Journal:  J Infect Dis       Date:  2013-10-31       Impact factor: 5.226

2.  Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.

Authors:  Bo Hyun Yoon; Roberto Romero; Jee Yoon Park; Kyung Joon Oh; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong
Journal:  Am J Obstet Gynecol       Date:  2019-03-27       Impact factor: 8.661

3.  The Paradoxical Effects of Chronic Intra-Amniotic Ureaplasma parvum Exposure on Ovine Fetal Brain Development.

Authors:  Ruth Gussenhoven; Daan R M G Ophelders; Matthew W Kemp; Matthew S Payne; Owen B Spiller; Michael L Beeton; Sarah J Stock; Bertha Cillero-Pastor; Florian P Y Barré; Ron M A Heeren; Lilian Kessels; Bas Stevens; Bart P Rutten; Suhas G Kallapur; Alan H Jobe; Boris W Kramer; Tim G A M Wolfs
Journal:  Dev Neurosci       Date:  2017-08-29       Impact factor: 2.984

Review 4.  Ureaplasma species: role in diseases of prematurity.

Authors:  Rose M Viscardi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

5.  Twenty-four percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation.

Authors:  Kyung Joon Oh; Sun Min Kim; Joon-Seok Hong; Eli Maymon; Offer Erez; Bogdan Panaitescu; Nardhy Gomez-Lopez; Roberto Romero; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2017-02-28       Impact factor: 8.661

6.  Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation.

Authors:  I Nicholas Olomu; Jonathan L Hecht; Andrew O Onderdonk; Elizabeth N Allred; Alan Leviton
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

7.  Gastric fluid versus amniotic fluid analysis for the identification of intra-amniotic infection due to Ureaplasma species.

Authors:  Sun Min Kim; Roberto Romero; JoonHo Lee; Piya Chaemsaithong; Nikolina Docheva; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-02

Review 8.  Animal models of bronchopulmonary dysplasia. The preterm baboon models.

Authors:  Bradley A Yoder; Jacqueline J Coalson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-03       Impact factor: 5.464

9.  Placental Infection With Ureaplasma species Is Associated With Histologic Chorioamnionitis and Adverse Outcomes in Moderately Preterm and Late-Preterm Infants.

Authors:  Emma L Sweeney; Suhas G Kallapur; Tate Gisslen; Donna S Lambers; Claire A Chougnet; Sally-Anne Stephenson; Alan H Jobe; Christine L Knox
Journal:  J Infect Dis       Date:  2015-12-15       Impact factor: 5.226

10.  Does Ureaplasma spp. cause chronic lung disease of prematurity: ask the audience?

Authors:  Nicola C Maxwell; Diane Nuttall; Sailesh Kotecha
Journal:  Early Hum Dev       Date:  2009-01-13       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.